Sort
53,477 grants matching “addiction”
Selective Kv7.2/3 activators for the treatment of neuropathic pain
$1,493,500Armando Signore · Knopp Biosciences, Llc · U44 · FY2019 · NS
2/24 Healthy Brain and Child Development National Consortium
$1,493,392Pat R Levitt · Children'S Hospital Of Los Angeles · U01 · FY2023 · DA
Center on Intersystem Regulation by Drugs of Abuse
$1,492,617Ellen M Unterwald · Temple Univ Of The Commonwealth · P30 · FY2024 · DA
Center on Intersystem Regulation by Drugs of Abuse
$1,492,617Ellen M Unterwald · Temple Univ Of The Commonwealth · P30 · FY2023 · DA
Center on Intersystem Regulation by Drugs of Abuse
$1,492,617Ellen M Unterwald · Temple Univ Of The Commonwealth · P30 · FY2022 · DA
Center on Intersystem Regulation by Drugs of Abuse
$1,492,617Ellen M Unterwald · Temple Univ Of The Commonwealth · P30 · FY2021 · DA
DRUGS OF ABUSE--ROLE OF PROTEIN PHOSPHORYLATION
$1,492,413Rockefeller University · P01 · FY2004 · DA
Yale/NIDA Neuroproteomics Research Center
$1,492,197Yale University · P30 · FY2005 · DA
IND-enabling studies on novel Cav3 T-channel modulators for treatment of neuropathic pain
$1,491,977Xinmin Simon Xie · Afasci, Inc. · R44 · FY2018 · NS
Deep TMS Neuromodulation of Neural Circuits Associated with Stimulant Use Disorder
$1,491,755Claudia B. Padula · Stanford University · UG3 · FY2024 · DA
MUSC Specialized Center of Research Excellence on Sex Differences Renewal 2022
$1,491,732Aimee L McRae-Clark · Medical University Of South Carolina · U54 · FY2023 · DA
IND-enabling studies on novel Cav3 T-channel modulators for treatment of neuropathic pain
$1,491,584Xinmin Simon Xie · Afasci, Inc. · R44 · FY2020 · NS
Elucidation of Leukocyte and Macrophage Biomarker Signatures from Drugs of Abuse
$1,491,067John Alan McLean · Vanderbilt University · RC2 · FY2009 · DA
6/6 HBCD Prenatal Experiences and Longitudinal Development (PRELUDE) Consortium Vanderbilt
$1,490,524Laurie E Cutting · Vanderbilt University · U01 · FY2022 · DA
Development and Optimization of MNK Inhibitors for the Treatment of Neuropathic Pain
$1,489,451James Jeffrey Sahn · 4e Therapeutics Inc. · U44 · FY2019 · NS
Yale/NIDA Neuroproteomics Research Center
$1,489,308Yale University · P30 · FY2004 · DA
Potassium Channels and Dendritic Function in Hippocampal Pyramidal Neurons
$1,488,954Dax A Hoffman · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD
Development of an oral analgesic with reduced liabilities
$1,488,866Donald R Gehlert · Epiodyne, Inc. · R44 · FY2023 · DA
Optimizing HIV-care-continuum engagement and outcomes among opioid users
$1,488,838David Epstein · National Institute On Drug Abuse · ZIA · FY2020 · DA
Optimizing HIV-care-continuum engagement and outcomes among opioid users
$1,488,838David Epstein · National Institute On Drug Abuse · ZIA · FY2021 · DA
Single Cell Transcriptomics of the Cocaine Use Disorder in the Context of HIV
$1,487,129Christine Cheng · University Of California, San Diego · U01 · FY2024 · DA
ADMINISTRATIVE CORE
$1,486,613Eric Christian Donny · University Of Pittsburgh At Pittsburgh · U54 · FY2014 · DA
Development of a5* nAChR positive allosteric modulators for tobacco dependence
$1,486,387Paul J Kenny · Scripps Research Institute, The · R01 · FY2013 · DA
NEURAL MECHANISMS OF ADAPTIVE BEHAVIOR
$1,486,353University Of South Dakota · P20 · FY2005 · RR
Medication Development for the Treatment of Alcohol Use Disorder
$1,486,106Susan E. Bergeson · Texas Tech University Health Scis Center · U01 · FY2021 · AA